History repeating: guidelines to address common problems in psychedelic science

M van Elk, EI Fried - Therapeutic Advances in …, 2023 - journals.sagepub.com
Research in the last decade has expressed considerable optimism about the clinical
potential of psychedelics for the treatment of mental disorders. This optimism is reflected in …

Therapeutic potential of psychedelic drugs: navigating high hopes, strong claims, weak evidence, and big money

K Humphreys, P Todd Korthuis… - Annual Review of …, 2024 - annualreviews.org
Therapeutic claims about many psychedelic drugs have not been evaluated in any studies
of even modest rigor. The science of psychedelic drugs is strengthening however, making it …

[HTML][HTML] Suicidal ideation

B Harmer, S Lee, TVH Duong, A Saadabadi - 2020 - europepmc.org
Suicidal ideations (SI), often called suicidal thoughts or ideas, is a broad term used to
describe a range of contemplations, wishes, and preoccupations with death and suicide …

The molecular pathophysiology of depression and the new therapeutics

H Tian, Z Hu, J Xu, C Wang - MedComm, 2022 - Wiley Online Library
Major depressive disorder (MDD) is a highly prevalent and disabling disorder. Despite the
many hypotheses proposed to understand the molecular pathophysiology of depression, it is …

[HTML][HTML] At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: findings from a large, prospective …

TD Hull, M Malgaroli, A Gazzaley, TJ Akiki… - Journal of Affective …, 2022 - Elsevier
Abstract Background At-home Ketamine-assisted therapy (KAT) with psychosocial support
and remote monitoring through telehealth platforms addresses access barriers, including the …

[HTML][HTML] Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review

F Jollant, R Colle, TML Nguyen… - Therapeutic …, 2023 - journals.sagepub.com
Background: More than 2% of the general population experience suicidal ideas each year
and a large number of them will attempt suicide. Evidence-based therapeutic options to …

Ketamine in neuropsychiatric disorders: an update

JN Johnston, B Kadriu, C Kraus, ID Henter… - …, 2024 - nature.com
The discovery of ketamine as a rapid-acting antidepressant led to a new era in the
development of neuropsychiatric therapeutics, one characterized by an antidepressant …

Effect of repeated intravenous esketamine on adolescents with major depressive disorder and suicidal ideation: a randomized active-placebo-controlled trial

Y Zhou, X Lan, C Wang, F Zhang, H Liu, L Fu… - Journal of the American …, 2024 - Elsevier
Objective Suicide is a major cause of death in adolescents with limited treatment options.
Ketamine and its enantiomers have shown rapid anti-suicidal effects in adults with major …

Oral ketamine for depression: an updated systematic review

S Meshkat, S Haikazian, JD Di Vincenzo… - The World Journal of …, 2023 - Taylor & Francis
Objectives: Ketamine is a glutamate N-methyl-D-aspartate receptor antagonist that can be
used to treat major depressive disorder by single or repeated infusions. However, the …

The clinical toxicology of ketamine

LJ Schep, RJ Slaughter, M Watts, E Mackenzie… - Clinical …, 2023 - Taylor & Francis
Introduction Ketamine is a pharmaceutical drug possessing both analgesic and anaesthetic
properties. As an anaesthetic, it induces anaesthesia by producing analgesia with a state of …